FTC – WellAI's Original Blogs

Digital Health Market Startup Lessons

🔮 2025 Digital Health Predictions and Reflections on 2024’s Hits & Misses

December 31, 2024December 31, 2024 admin 0 Comments 23andMe, Acquisitions, AI agents, AI fraud, AI scribe, AI tourists, API, Augmedix, Babylon Health, bankruptcy, Bitcoin, Blockchain, BTC, Commure, Delisting, Digital Health, Digital health failures, EHR, EMR, EU, fraud, FTC, GLP-1, Innovation, IPO, Livongo, Lobbying, M&A, Medicare fraud, Nuvo Cares, Olive AI, Optum Ventures, Outcome Health, PBM, PE, Pieces Technologies, Private equity, R1 RCM, SCWorx Corp, Suki, The Data Act, Truepill, UnitedHealth, VC, VC bro culture, VC bros, Venture capital, Walmart, Walmart Health

2024 was the year of “AI tourists” in healthcare. Will 2025 finally bring innovation in digital health? Continue reading this

Digital Health Market

A Message to Digital Health Founders: There is No Money in Disease Prevention. Come Back in 10 Years.

February 27, 2024 admin 0 Comments Antitrust, Bright Health, Clover Health, Dermatology, Digital Health, Disease Prevention, Drug Discovery, EHR, Epic, Fee-For-Service (FFS), FTC, Genomics, GoHealth, Inflation Reduction Act, Insuretech, Mammography, Medical Advice, medical diagnosis, Monetization, Oscar Health, Pharmacy Benefit Manager (PBM), Radiology, Robotics, startup, Startup Founders, Startup Lessons, Startup Life, The Affordable Care Act (ACA), Treatment, Venture capital

Monetization is a real challenge in digital health. Making money in healthcare tech is tough. Whether it’s governments or insurance

Why Do Cops Trust AI, But Doctors Don’t?

January 31, 2024 admin 0 Comments AI Biases, AI Ethics, FDA, fraud, FTC, Patient Safety, Responsible AI

The answer lies in incentives and motivation. It’s the “catch the bad guy at all costs” versus “protect the patient

Venture Capital

“We Bought a Hospital We Couldn’t Afford”: General Catalyst Becomes General Hospital

January 20, 2024 admin 0 Comments Acquisitions, Antitrust, Digital Health, FTC, General Catalyst, Hospital, Leveraged Buyout (LBO), Livongo, M&A, Private equity, Summa Health, Teladoc, Venture capital

If someone, other than Houdini, has $1 billion and decides to buy something for $2 billion, the math simply doesn’t